Literature DB >> 4092192

Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modulation.

A Russo, J B Mitchell.   

Abstract

One of the proposed mechanisms of doxorubicin cytotoxicity is generation of activated oxygen species, all of which are either free radical or potentially free radical species. Glutathione is an intracellular sulfhydryl-containing tripeptide that is known to detoxify free radicals and the damage they produce. The cytotoxicity of doxorubicin was evaluated following treatment with agents that will either elevate intracellular glutathione (2-oxothiazolidine-4-carboxylate) or deplete intracellular glutathione levels correlate with doxorubicin cytotoxicity, ie, elevated glutathione provides protection and decreased glutathione levels increase cytotoxicity. These results are discussed in the context of cardiac toxicity as well as enhancing tumor cell kill with doxorubicin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092192

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  12 in total

1.  Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats.

Authors:  C Coudray; S Mouhieddine; M J Richard; J Arnaud; J De Leiris; A Favier
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

Review 2.  Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy.

Authors:  Loreto B Feril; Takashi Kondo; Shin-Ichiro Umemura; Katsuro Tachibana; Angelo H Manalo; Peter Riesz
Journal:  J Med Ultrason (2001)       Date:  2002-12       Impact factor: 1.314

3.  Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.

Authors:  A Canada; L Herman; K Kidd; C Robertson; D Trump
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 4.  The role of glutathione in radiation and drug induced cytotoxicity.

Authors:  J B Mitchell; A Russo
Journal:  Br J Cancer Suppl       Date:  1987-06

5.  L-2-oxothiazolidine-4-carboxylate protects cultured endothelial cells against hyperoxia-induced injury.

Authors:  M F Tsan; P G Phillips
Journal:  Inflammation       Date:  1988-04       Impact factor: 4.092

Review 6.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.

Authors:  R T Dorr; J D Liddil; M J Soble
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

8.  Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.

Authors:  T Asakura; K Ohkawa; N Takahashi; K Takada; T Inoue; S Yokoyama
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Glutathione and related enzyme activity in human lung cancer cell lines.

Authors:  J Carmichael; J B Mitchell; N Friedman; A F Gazdar; A Russo
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

10.  The use of 1H spin echo NMR and HPLC to confirm doxorubicin induced depletion of glutathione in the intact HeLa cell.

Authors:  M al-Kabban; I D Watson; M J Stewart; J Reglinski; W E Smith; C J Suckling
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.